Zobrazeno 1 - 10
of 70
pro vyhledávání: '"selepressin"'
Publikováno v:
In Peptides July 2020 129
Publikováno v:
Journal of Intensive Care, Vol 8, Iss 1, Pp 1-11 (2020)
Abstract Background Norepinephrine (NE) has currently been the first-choice vasopressor in treating septic shock despite generally insufficient for patients with refractory septic shock. The aim of this update meta-analysis was to assess the safety a
Externí odkaz:
https://doaj.org/article/c93c259ec91e4bb48136f48af26e33b4
Autor:
Ren-qi Yao, De-meng Xia, Li-xue Wang, Guo-sheng Wu, Yi-bing Zhu, Hong-qiang Zhao, Qi Liu, Zhao-fan Xia, Chao Ren, Yong-ming Yao
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundVasopressin is an efficient remedy for septic shock patients as its great capacity in promoting hemodynamic stabilization. The aim of current systematic review and meta-analysis is to compare the clinical efficiency of vasopressin or its an
Externí odkaz:
https://doaj.org/article/cabbe97ec0b44f09b3a621ef35ad6fe5
Autor:
James A. Russell, Jean-Louis Vincent, Anne Louise Kjølbye, Håkan Olsson, Allan Blemings, Herbert Spapen, Peder Carl, Pierre-Francois Laterre, Lars Grundemar
Publikováno v:
Critical Care, Vol 21, Iss 1, Pp 1-10 (2017)
Abstract Background Vasopressin is widely used for vasopressor support in septic shock patients, but experimental evidence suggests that selective V1A agonists are superior. The initial pharmacodynamic effects, pharmacokinetics, and safety of selepre
Externí odkaz:
https://doaj.org/article/505f99780d0745ac933aa3723f311773
Publikováno v:
In Best Practice & Research Clinical Anaesthesiology December 2016 30(4):465-477
Autor:
Keith R. Walley, Anthony C. Gordon, Mark D. Williams, Niranjan Kissoon, John H. Boyd, James A. Russell
Publikováno v:
Seminars in Respiratory and Critical Care Medicine. 42:059-077
After fluid administration for vasodilatory shock, vasopressors are commonly infused. Causes of vasodilatory shock include septic shock, post-cardiovascular surgery, post-acute myocardial infarction, postsurgery, other causes of an intense systemic i
Autor:
Lopa, Ahsina Jahan, Bhattacharjee, Sulagna, Mishra, Rajesh Chandra, Ahmed, Ahsan, Sinha, Sharmili
Publikováno v:
In The Sepsis Codex 2023:121-133
Autor:
Nektarios Barabutis, Mohammad A. Uddin, John D Catravas, Margarita Marinova, Glenn E Croston, Pavel Solopov, Torsten M Reinheimer
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 375:286-295
Sepsis and septic shock are among the most common causes of death in the intensive care unit; advanced therapeutic approaches are thus urgently needed. Vascular hyperpermeability represents a major manifestation of severe sepsis and is responsible fo
Publikováno v:
Obŝaâ Reanimatologiâ, Vol 16, Iss 2, Pp 77-93 (2020)
Septic shock, as the most severe form of sepsis, is characterized by high mortality reaching 40% despite the use of the most modern standards of diagnosis and treatment. In the thanatogenesis of septic shock, vasoplegia plays a leading role, respecti
Autor:
Pierre Asfar, Julien Demiselle
Publikováno v:
Médecine Intensive Réanimation. 29:17-23
Le système vasopressinergique est l’un des systèmes activés en réponse à une baisse de la pression artérielle. La vasopressine, hormone de stress, entraîne après sa fixation sur les récepteurs V1a des cellules musculaires lisses vasculaire